Aileron Therapeutics (ALRN) Stock Price, News & Analysis
Company Description
Aileron Therapeutics (NASDAQ: ALRN) is classified in the pharmaceutical preparation manufacturing industry within the Pharmaceutical Preparations sector and carries a market capitalization of $45.7M, ranking #5,832 among all listed U.S. companies by market cap.
ALRN has declined 43.0% over the past year. Shares last traded at $2.11.
This page collects what Stock Titan holds for ALRN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aileron Therapeutics (ALRN) stock last closed at $2.11. Over the past 12 months, the stock has lost 43.0%. At a market capitalization of $45.7M, ALRN is classified as a micro-cap stock with approximately 21.7M shares outstanding.
ALRN Rankings
Latest News
Aileron Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, clinical trial, acquisition, conferences. View all ALRN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ALRN Company Profile & Sector Positioning
Aileron Therapeutics (ALRN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.